Form 4: Omada Health Insider Sells Shares Under 10b5-1 Plan

Omada Health Chief Accounting Officer Craig Gracey sold shares of common stock through a pre-arranged trading plan designed to comply with Rule 10b5-1.

Summary

• Craig Gracey, Chief Accounting Officer at Omada Health, Inc., reported transactions involving the sale of company common stock.
• On June 26, 2026, 2,084 shares were sold at a price of $20 per share.
• On June 29, 2026, an additional 2,083 shares were sold at a price of $21 per share.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on March 13, 2026.
• Following these sales, Gracey beneficially owns 858 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as the reported stock sales were conducted under a pre-arranged Rule 10b5-1 plan, which is a standard and compliant method for insiders to manage their stock holdings.

Negatives

• Insider selling of company stock can sometimes be perceived negatively by the market, although in this case, it was conducted under a pre-established trading plan.

Risks

• The primary risk associated with insider selling, even under a 10b5-1 plan, is the potential for negative market perception if not adequately contextualized.
• The company's stock performance is subject to market volatility and the overall health technology sector trends.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the company. The transactions reported are based on a pre-existing trading plan.

Industry Context

StockSavvy.ai notes that the use of Rule 10b5-1 plans by insiders is a common practice to diversify holdings or meet financial obligations while mitigating concerns about insider trading. This filing indicates standard procedural compliance rather than a change in management's outlook on the company's prospects.

Corporate Governance

Stakeholder Impact

• Shareholders: The sales, being part of a pre-planned strategy, are unlikely to signal a negative outlook on the company's future, but any insider selling can be a point of observation.
• Employees: May observe insider activity as an indicator of executive confidence, though the 10b5-1 plan mitigates direct interpretation.
• Management: Demonstrates compliance with regulatory requirements and established trading policies.

Next Steps

• Continued monitoring of insider transactions for any further changes in beneficial ownership.
• Observation of Omada Health's future financial performance and strategic announcements.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Chief Accounting Officer, Beneficial Ownership, Securities Exchange Act